Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

Clinical trial NCT00401011 · COMPLETED

Trial details

NCT number: NCT00401011
Sponsor: AEterna Zentaris
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma in Relapse

Start date: 2006-08-01
Primary completion: 2010-12-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.